BAK1 antibodies are polyclonal or monoclonal antibodies that bind specifically to the BAK1 protein, a pro-apoptotic member of the BCL-2 family. BAK1 localizes to the mitochondrial outer membrane (MOM) and mediates apoptosis by forming oligomeric pores, enabling cytochrome c release . These antibodies are used to study BAK1’s interactions, expression patterns, and functional roles in health and disease.
BAK1 antibodies are utilized in diverse experimental contexts:
Western Blotting (WB): Detects BAK1 expression in mitochondrial extracts .
Immunoprecipitation (IP): Identifies BAK1 interactions with BCL-2, BAX, and p53 .
Immunofluorescence (IF): Visualizes BAK1 localization to mitochondria .
Plant Biology: Studies BAK1’s role in brassinosteroid signaling and pathogen defense in Arabidopsis .
BAK1 antibodies have highlighted the protein’s dual role in disease:
Cancer: Reduced BAK1 activity correlates with tumor progression (e.g., colorectal cancer) .
Neurodegeneration: Overactive BAK1 contributes to neuronal apoptosis .
Autoimmunity: Dysregulated BAK1 in immune cells exacerbates autoimmune responses .
BH3 mimetics: Small molecules inhibiting BAK1/BCL-2 interactions .
miRNA regulators: miR-410 suppression restores BAK1-mediated apoptosis in CRC .
BAK1 (BRI1-Associated Kinase 1) is a dual-specificity kinase that acts on serine/threonine and tyrosine residues. It plays a crucial role in regulating the expression of genes involved in innate immunity, particularly in the absence of pathogens or elicitors. BAK1 is a key component of brassinosteroid (BR) signal transduction, phosphorylating BRI1 (Brassinosteroid Insensitive 1). It modulates the equilibrium between plasma membrane-localized BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 (BRI1-Suppressor 1) promotes BAK1 endocytosis and suppresses BR signaling. BAK1 participates in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) through interactions with FLS2 (Flagellin Sensing 2) and EFR (EF-Tu Receptor), and the subsequent phosphorylation of BIK1 (Botrytis-induced Kinase 1). It also influences programmed cell death (PCD) control. BAK1 positively regulates BR-dependent plant growth and negatively regulates BR-independent cell death. It phosphorylates BIR2 (BAK1-interacting Receptor-like Kinase 2), enhancing their interaction and preventing BIR2 from interacting with FLS2 in the absence of PAMPs. BAK1 is a component of the RLP23-SOBIR1-BAK1 complex mediating NLP (Necrosis and ethylene-inducing peptide 1)-triggered immunity. It is essential for PSK (Phytochrome Signaling Kinase)-mediated promotion of seedling growth and protoplast expansion. Furthermore, BAK1, along with CNGC17 (Cyclic Nucleotide-Gated Channel 17) and AHAs (Auxin-responsive Histidine Kinase), forms a functional cation-translocating unit activated by PSKR1/BAK1 and potentially other BAK1/RLK complexes. BAK1 is likely involved in small peptide signaling (e.g., RGF1, Root Growth Factor 1).
KEGG: ath:AT4G33430
UniGene: At.376